🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer

RecruitingNAAges 18 Years - anyMaleCedars-Sinai Medical Center
NCT06856694 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of the research is to assess the impact of a natural language processing + artificial intelligence (NLP+AI)-based risk communication feedback system to improve quality of risk communication of key tradeoffs during prostate cancer consultations among physicians and to improve patient decision making. In this cluster randomized trial, an evaluable 259 patients with newly diagnosed clinically localized prostate cancer will be cluster randomized within an evaluable 24 physicians to: 1. a control arm, in which patients will receive standard of care treatment consultations along with AUA-endorsed educational materials on treatment risks and benefits (for patients) and on SDM (for physicians) or 2. an experimental arm, in which patients and participating physicians will receive NLP+AI-based feedback on what was said about key tradeoffs within approximately 72 hours of the consultat

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Physician Inclusion Criteria (1) Physicians who typically counsel prostate cancer patients (Urology, Radiation Oncology, Medical Oncology) Patient Inclusion Criteria 1. Patients undergoing initial treatment consultation for clinically localized prostate cancer; 2. Patients with upgraded prostate cancer on active surveillance considering conversion to definitive local therapy; 3. Ability to read and write in English. Patient Exclusion Criteria: 1. Under 18 years of age; 2. Subjects with difficulty communicating or dementia; 3. Non-English speakers, given that our NLP-based tools cannot be used with languages other than English; 4. Patients with locally advanced or metastatic prostate cancer; 5. Patients who have already been treated for clinically localized prostate cancer.
💊

What it tests

  • NLP+AI Report
📍

Where

1 site
Cedars Sinai Medical Center
Los Angeles, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy